Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewAM 9022 is a potent and selective KIF18A inhibitor (IC50 = 60 nM). It displays selectivity for KIF18A over a panel of diverse kinesin motor proteins. Upon blocking MT-ATPase motor activity (non-competitive with ATP and MTs), it activates the mitotic checkpoint and selectively kills chromosomally unstable cancer cells. Has minimal detrimental effects on human bone marrow cells in culture, distinct from other anti-mitotic agents. In mice, inhibition of KIF18A leads to robust anti-cancer effects with tumor regression observed in human HGSOC and TNBC models at well-tolerated doses. AM 9022 can be used for the selective targeting of CIN cancers.
| M. Wt | 578.68 |
| Formula | C27H36F2N6O4S |
| Storage | Store at -20°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 2446872-46-2 |
| PubChem ID | 148785380 |
| InChI Key | OLCRYQGHHMGOJZ-LJQANCHMSA-N |
| Smiles | CC1=CC(NC(C2=C(C=C(C=C2)NS([C@H](C)CO)(=O)=O)N3CCC4(CC3)CC4)=O)=NC(N5CCC(F)(CC5)F)=N1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 57.87 | 100 |
The following data is based on the product molecular weight 578.68. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.73 mL | 8.64 mL | 17.28 mL |
| 5 mM | 0.35 mL | 1.73 mL | 3.46 mL |
| 10 mM | 0.17 mL | 0.86 mL | 1.73 mL |
| 50 mM | 0.03 mL | 0.17 mL | 0.35 mL |
References are publications that support the biological activity of the product.
Payton et al (2023) Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers. Nature Cancer 5 66 PMID: 38151625
If you know of a relevant reference for AM 9022, please let us know.
Keywords: AM 9022, AM 9022 supplier, AM9022, potent, selective, inhibitor, inhibits, KIF18A, mitotic, checkpoint, kinesin, oncology, cancer, research, Checkpoint, Control, Kinases, 8969, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for AM 9022. Do you know of a great paper that uses AM 9022 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review AM 9022 and earn rewards!
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:
In normal cells, each stage of the cell cycle is tightly regulated, however in cancer cells many genes and proteins that are involved in the regulation of the cell cycle are mutated or over expressed. This poster summarizes the stages of the cell cycle and DNA repair. It also highlights strategies for enhancing replicative stress in cancer cells to force mitotic catastrophe and cell death.